Bradykinin-induced asthmatic fibroblast/myofibroblast activities via bradykinin B2 receptor and different MAPK pathways.

[1]  G. Béréziat,et al.  Wild‐type amyloid beta 1‐40 peptide induces vascular smooth muscle cell death independently from matrix metalloprotease activity , 2012, Aging cell.

[2]  P. Séguéla,et al.  Role of ßarrestins in bradykinin B2 receptor-mediated signalling. , 2011, Cellular signalling.

[3]  A. Kaplan,et al.  The plasma bradykinin-forming pathways and its interrelationships with complement. , 2010, Molecular immunology.

[4]  C. Billington,et al.  Can lineage-specific markers be identified to characterize mesenchyme-derived cell populations in the human airways? , 2010, American journal of physiology. Lung cellular and molecular physiology.

[5]  L. Petecchia,et al.  Mechanisms of bradykinin-induced contraction in human fetal lung fibroblasts , 2010, European Respiratory Journal.

[6]  Yunchao Su,et al.  α‐Defensins increase lung fibroblast proliferation and collagen synthesis via the β‐catenin signaling pathway , 2009, The FEBS journal.

[7]  Ravi Salgia,et al.  Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer , 2008, Journal of carcinogenesis.

[8]  U. Lerner,et al.  Kinin B1 and B2 receptor expression in osteoblasts and fibroblasts is enhanced by interleukin-1 and tumour necrosis factor-alpha. Effects dependent on activation of NF-kappaB and MAP kinases. , 2008, Bone.

[9]  D. Broide.  Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. , 2008, The Journal of allergy and clinical immunology.

[10]  P. Sterk,et al.  Asthma therapy and airway remodeling. , 2007, The Journal of allergy and clinical immunology.

[11]  Joo-Hwan Kim,et al.  p38 MAPK and ERK activation by 9-cis-retinoic acid induces chemokine receptors CCR1 and CCR2 expression in human monocytic THP-1 cells , 2007, Experimental & Molecular Medicine.

[12]  J. Foster,et al.  Activation of elastin transcription by transforming growth factor-beta in human lung fibroblasts. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[13]  J. Martin,et al.  Basic mechanisms of development of airway structural changes in asthma , 2006, European Respiratory Journal.

[14]  S. Wenzel,et al.  Myofibroblast or smooth muscle: do in vitro systems adequately replicate tissue smooth muscle? , 2006, American journal of respiratory and critical care medicine.

[15]  S. Wenzel,et al.  Regional fibroblast heterogeneity in the lung: implications for remodeling. , 2006, American journal of respiratory and critical care medicine.

[16]  L. Petecchia,et al.  The effect of transforming growth factor (TGF)-β1 and (TGF)-β2 on nasal polyp fibroblast activities involved upper airway remodeling: Modulation by fluticasone propionate , 2006 .

[17]  Biao Hu,et al.  Telomerase regulation of myofibroblast differentiation. , 2006, American journal of respiratory cell and molecular biology.

[18]  M. Caruso,et al.  Bradykinin differentiates human lung fibroblasts to a myofibroblast phenotype via the B2 receptor. , 2005, The Journal of allergy and clinical immunology.

[19]  K. Rabe,et al.  Effects of cigarette smoke condensate on proliferation and wound closure of bronchial epithelial cells in vitro: role of glutathione , 2005, Respiratory research.

[20]  E. Puré,et al.  TGF-β potentiates airway smooth muscle responsiveness to bradykinin , 2005 .

[21]  J. Gratton,et al.  Dissociation of beta-arrestin from internalized bradykinin B2 receptor is necessary for receptor recycling and resensitization. , 2005, Cellular signalling.

[22]  L. Petecchia,et al.  Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities , 2005, Laboratory Investigation.

[23]  F. Marceau,et al.  International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences , 2005, Pharmacological Reviews.

[24]  J. Malmström,et al.  Presence of activated mobile fibroblasts in bronchoalveolar lavage from patients with mild asthma. , 2004, American journal of respiratory and critical care medicine.

[25]  T. Monks,et al.  EGFR-independent activation of p38 MAPK and EGFR-dependent activation of ERK1/2 are required for ROS-induced renal cell death. , 2004, American journal of physiology. Renal physiology.

[26]  Yaping Zhang,et al.  Up-regulation of bradykinin receptors in a murine in-vitro model of chronic airway inflammation. , 2004, European journal of pharmacology.

[27]  K. Rabe,et al.  Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. , 2004, American journal of respiratory cell and molecular biology.

[28]  Irina Kalatskaya,et al.  Downregulation of bradykinin B2 receptor in human fibroblasts during prolonged agonist exposure. , 2003, American journal of physiology. Heart and circulatory physiology.

[29]  D. Mierke,et al.  Mechanisms regulating the expression, self‐maintenance, and signaling‐function of the bradykinin B2 and B1 receptors , 2002, Journal of cellular physiology.

[30]  T. Ishizuka,et al.  4-Hydroxy-2-nonenal enhances fibronectin production by IMR-90 human lung fibroblasts partly via activation of epidermal growth factor receptor-linked extracellular signal-regulated kinase p44/42 pathway. , 2002, Toxicology and applied pharmacology.

[31]  M. Silverberg,et al.  Pathways for bradykinin formation and inflammatory disease. , 2002, The Journal of allergy and clinical immunology.

[32]  C. Liebmann,et al.  Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. , 2001, Cellular signalling.

[33]  A. Zwinderman,et al.  Factors associated with persistent airflow limitation in severe asthma. , 2001, American journal of respiratory and critical care medicine.

[34]  P. Sterk,et al.  Allergen-induced impairment of bronchoprotective nitric oxide synthesis in asthma. , 2001, The Journal of allergy and clinical immunology.

[35]  D. Romberger,et al.  Bradykinin augments fibroblast-mediated contraction of released collagen gels. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[36]  P. Cohen,et al.  Specificity and mechanism of action of some commonly used protein kinase inhibitors , 2000 .

[37]  P. McIntyre,et al.  Post-Transcriptional Regulation of Bradykinin B1 and B2 Receptor Gene Expression in Human Lung Fibroblasts by Tumor Necrosis Factor-α: Modulation by Dexamethasone , 2000 .

[38]  J. Nadel,et al.  Bradykinin increases intracellular calcium levels in a human bronchial epithelial cell line via the B2 receptor subtype , 1998, Inflammation Research.

[39]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[40]  J. Nadel,et al.  Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma , 1996, The Lancet.

[41]  B. Schölkens,et al.  Efficacy and tolerability of Icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma. , 1996, Immunopharmacology.

[42]  A. Ullrich,et al.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.

[43]  S. Young,et al.  Requirement of Transforming Growth Factor-β (TGF-β) Type II Receptor for TGF-β-induced Proliferation and Growth Inhibition (*) , 1996, The Journal of Biological Chemistry.

[44]  J. Nadel,et al.  Evidence for reduction of bradykinin‐induced bronchoconstriction in guinea‐pigs by release of nitric oxide , 1994, British journal of pharmacology.

[45]  D. Proud,et al.  Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. , 1992, The American review of respiratory disease.

[46]  S. Holgate,et al.  Cysteinyl leukotrienes synergize with growth factors to induce proliferation of human bronchial fibroblasts. , 2007, The Journal of allergy and clinical immunology.

[47]  A. Fischer,et al.  Detection of nitric oxide release induced by bradykinin in guinea pig trachea and main bronchi using a porphyrinic microsensor. , 2000, American journal of respiratory cell and molecular biology.

[48]  J. Hall,et al.  Bradykinin receptors: pharmacological properties and biological roles. , 1992, Pharmacology & therapeutics.